Insider activity at TG Therapeutics, Inc. has been all selling for a year now: about $438,000 from two sellers, and zero buyers with their own money.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
On the institutional side, 428 funds reported holding TGTX at the end of Q2 2026, and more funds bought than sold. Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Charney Laurence N | Director | Sell | 5,000 | $54.96 | $275K | SEC |
| Nov 25, 2025 | Echelard Yann | Director | Sell | 5,000 | $32.57 | $163K | SEC |
| Sep 12, 2025 | Lonial Sagar | Director | Sell | 20,852 | $32.24 | $672K | SEC |
| Jun 16, 2025 | Echelard Yann | Director | Sell | 10,000 | $36.94 | $369K | SEC |
| Jan 7, 2025 | Power Sean A | CFO | Sell | 11,337 | $30.29 | $343K | SEC |
| Jan 7, 2025 | Power Sean A | CFO | Sell | 10,021 | $28.53 | $286K | SEC |
| Nov 12, 2024 | Lonial Sagar | Director | Sell | 5,000 | $30.44 | $152K | SEC |
| Nov 12, 2024 | Charney Laurence N | Director | Sell | 25,000 | $30.20 | $755K | SEC |
| Nov 7, 2024 | Echelard Yann | Director | Sell | 20,000 | $24.48 | $490K | SEC |
| Jun 20, 2024 | Lonial Sagar | Director | Sell | 16,348 | $16.87 | $276K | SEC |
| Jun 20, 2024 | Lonial Sagar | Director | Sell | 9,585 | $16.39 | $157K | SEC |
| Mar 15, 2024 | Lonial Sagar | Director | Sell | 5,000 | $15.94 | $80K | SEC |
| Mar 13, 2024 | Charney Laurence N | Director | Sell | 22,000 | $15.97 | $351K | SEC |
| Jan 8, 2024 | Charney Laurence N | Director | Sell | 17,500 | $19.03 | $333K | SEC |
| Jan 5, 2024 | Power Sean A | CFO | Sell | 47,867 | $16.91 | $809K | SEC |
In the last 12 months TG Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $438,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in TGTX was filed on 2026-09-14.
428 investment managers reported holding TGTX in SEC Form 13F filings for Q2 2026.
No congressional trades in TGTX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).